Induction of Alzheimer-specific tau epitope AT100 in apoptotic human fetal astrocytes

Hanna Ksiezak-Reding, Deke He, Wanda Gordon-Krajcer, Yvonne Kress, Sunhee Lee, Dennis W. Dickson

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

In Alzheimer's and other neurodegenerative diseases, hyperphosphorylated tau accumulates in affected neuronal and glial cells in the form of paired helical filaments (PHFs). This tau binds antibody AT100, which recognizes the double phosphorylation site (Thr212/Ser214) that is not present in normal biopsy tau. In primary cultures, highly enriched (>98%) in astrocytes of human fetal brain, three polypeptides of 52, 64, and 70 kD showed immunoreactivity with tau antibodies against non-phosphorylated epitopes, accounting for 88, 12, and <1%, respectively, of the total reactivity. All three polypeptides were phosphorylated at the PHF-1 epitope but not at the epitopes Tau-1, 12E8, AT8, and AT100. Treatment of cultures with okadaic acid resulted in apoptosis characterized by the blebbing of the plasma membrane, condensation of nuclear chromatin, and fragmentation of the nucleus. This treatment also resulted in a 3- to 5-fold increase in the content of both tau protein and phosphorylation. The increases were observed in all phosphorylation sites examined, and included the AT100 site. The AT100 site has been proposed to be generated by protein kinase B/Akt and Cdc2. Since okadaic acid can induce an AD-like hyperphosphorylated state of normal tau in primary cultures of human brain cells, a simple cellular model is available permitting study of self-aggregation of tau and phosphorylation events characteristic of neurodegeneration. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)236-252
Number of pages17
JournalCell Motility and the Cytoskeleton
Volume47
Issue number3
DOIs
StatePublished - 2000

Fingerprint

Astrocytes
Epitopes
Phosphorylation
Okadaic Acid
tau Proteins
Proto-Oncogene Proteins c-akt
Peptides
Antibodies
Brain
Blister
Neuroglia
Neurodegenerative Diseases
Chromatin
Cell Membrane
Apoptosis
Biopsy

Keywords

  • Alzheimer's disease
  • Apoptosis
  • Okadaic acid
  • Primary cultures
  • Tau phosphorylation
  • Tau protein

ASJC Scopus subject areas

  • Cell Biology

Cite this

Induction of Alzheimer-specific tau epitope AT100 in apoptotic human fetal astrocytes. / Ksiezak-Reding, Hanna; He, Deke; Gordon-Krajcer, Wanda; Kress, Yvonne; Lee, Sunhee; Dickson, Dennis W.

In: Cell Motility and the Cytoskeleton, Vol. 47, No. 3, 2000, p. 236-252.

Research output: Contribution to journalArticle

Ksiezak-Reding, Hanna ; He, Deke ; Gordon-Krajcer, Wanda ; Kress, Yvonne ; Lee, Sunhee ; Dickson, Dennis W. / Induction of Alzheimer-specific tau epitope AT100 in apoptotic human fetal astrocytes. In: Cell Motility and the Cytoskeleton. 2000 ; Vol. 47, No. 3. pp. 236-252.
@article{71ce1012ba18436582200041f96ff32e,
title = "Induction of Alzheimer-specific tau epitope AT100 in apoptotic human fetal astrocytes",
abstract = "In Alzheimer's and other neurodegenerative diseases, hyperphosphorylated tau accumulates in affected neuronal and glial cells in the form of paired helical filaments (PHFs). This tau binds antibody AT100, which recognizes the double phosphorylation site (Thr212/Ser214) that is not present in normal biopsy tau. In primary cultures, highly enriched (>98{\%}) in astrocytes of human fetal brain, three polypeptides of 52, 64, and 70 kD showed immunoreactivity with tau antibodies against non-phosphorylated epitopes, accounting for 88, 12, and <1{\%}, respectively, of the total reactivity. All three polypeptides were phosphorylated at the PHF-1 epitope but not at the epitopes Tau-1, 12E8, AT8, and AT100. Treatment of cultures with okadaic acid resulted in apoptosis characterized by the blebbing of the plasma membrane, condensation of nuclear chromatin, and fragmentation of the nucleus. This treatment also resulted in a 3- to 5-fold increase in the content of both tau protein and phosphorylation. The increases were observed in all phosphorylation sites examined, and included the AT100 site. The AT100 site has been proposed to be generated by protein kinase B/Akt and Cdc2. Since okadaic acid can induce an AD-like hyperphosphorylated state of normal tau in primary cultures of human brain cells, a simple cellular model is available permitting study of self-aggregation of tau and phosphorylation events characteristic of neurodegeneration. (C) 2000 Wiley-Liss, Inc.",
keywords = "Alzheimer's disease, Apoptosis, Okadaic acid, Primary cultures, Tau phosphorylation, Tau protein",
author = "Hanna Ksiezak-Reding and Deke He and Wanda Gordon-Krajcer and Yvonne Kress and Sunhee Lee and Dickson, {Dennis W.}",
year = "2000",
doi = "10.1002/1097-0169(200011)47:3<236::AID-CM6>3.0.CO;2-K",
language = "English (US)",
volume = "47",
pages = "236--252",
journal = "Cytoskeleton",
issn = "1949-3584",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Induction of Alzheimer-specific tau epitope AT100 in apoptotic human fetal astrocytes

AU - Ksiezak-Reding, Hanna

AU - He, Deke

AU - Gordon-Krajcer, Wanda

AU - Kress, Yvonne

AU - Lee, Sunhee

AU - Dickson, Dennis W.

PY - 2000

Y1 - 2000

N2 - In Alzheimer's and other neurodegenerative diseases, hyperphosphorylated tau accumulates in affected neuronal and glial cells in the form of paired helical filaments (PHFs). This tau binds antibody AT100, which recognizes the double phosphorylation site (Thr212/Ser214) that is not present in normal biopsy tau. In primary cultures, highly enriched (>98%) in astrocytes of human fetal brain, three polypeptides of 52, 64, and 70 kD showed immunoreactivity with tau antibodies against non-phosphorylated epitopes, accounting for 88, 12, and <1%, respectively, of the total reactivity. All three polypeptides were phosphorylated at the PHF-1 epitope but not at the epitopes Tau-1, 12E8, AT8, and AT100. Treatment of cultures with okadaic acid resulted in apoptosis characterized by the blebbing of the plasma membrane, condensation of nuclear chromatin, and fragmentation of the nucleus. This treatment also resulted in a 3- to 5-fold increase in the content of both tau protein and phosphorylation. The increases were observed in all phosphorylation sites examined, and included the AT100 site. The AT100 site has been proposed to be generated by protein kinase B/Akt and Cdc2. Since okadaic acid can induce an AD-like hyperphosphorylated state of normal tau in primary cultures of human brain cells, a simple cellular model is available permitting study of self-aggregation of tau and phosphorylation events characteristic of neurodegeneration. (C) 2000 Wiley-Liss, Inc.

AB - In Alzheimer's and other neurodegenerative diseases, hyperphosphorylated tau accumulates in affected neuronal and glial cells in the form of paired helical filaments (PHFs). This tau binds antibody AT100, which recognizes the double phosphorylation site (Thr212/Ser214) that is not present in normal biopsy tau. In primary cultures, highly enriched (>98%) in astrocytes of human fetal brain, three polypeptides of 52, 64, and 70 kD showed immunoreactivity with tau antibodies against non-phosphorylated epitopes, accounting for 88, 12, and <1%, respectively, of the total reactivity. All three polypeptides were phosphorylated at the PHF-1 epitope but not at the epitopes Tau-1, 12E8, AT8, and AT100. Treatment of cultures with okadaic acid resulted in apoptosis characterized by the blebbing of the plasma membrane, condensation of nuclear chromatin, and fragmentation of the nucleus. This treatment also resulted in a 3- to 5-fold increase in the content of both tau protein and phosphorylation. The increases were observed in all phosphorylation sites examined, and included the AT100 site. The AT100 site has been proposed to be generated by protein kinase B/Akt and Cdc2. Since okadaic acid can induce an AD-like hyperphosphorylated state of normal tau in primary cultures of human brain cells, a simple cellular model is available permitting study of self-aggregation of tau and phosphorylation events characteristic of neurodegeneration. (C) 2000 Wiley-Liss, Inc.

KW - Alzheimer's disease

KW - Apoptosis

KW - Okadaic acid

KW - Primary cultures

KW - Tau phosphorylation

KW - Tau protein

UR - http://www.scopus.com/inward/record.url?scp=0033744467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033744467&partnerID=8YFLogxK

U2 - 10.1002/1097-0169(200011)47:3<236::AID-CM6>3.0.CO;2-K

DO - 10.1002/1097-0169(200011)47:3<236::AID-CM6>3.0.CO;2-K

M3 - Article

C2 - 11056524

AN - SCOPUS:0033744467

VL - 47

SP - 236

EP - 252

JO - Cytoskeleton

JF - Cytoskeleton

SN - 1949-3584

IS - 3

ER -